Behavioral Healthcare Executive Skip to content Skip to navigation

Patient advocates back Senate bill’s approach to privacy

September 19, 2018  |  Tom Valentino, Senior Editor
news

The Legal Action Center is among the advocacy groups concerned that 42 CFR Part 2 changes contained in the House’s opioid bill could harm patient confidentiality.

Senate opioid bill passes, but industry leaders lament shortcomings

September 18, 2018  |  Tom Valentino, Senior Editor
news

Industry groups are disappointed over a lack of additional funding and the exclusion of 42 CFR Part 2 reform, and have also called for the removal the IMD exclusion for Medicaid patients.

Less new opioid use, more treatment offer signs of hope in national survey

September 18, 2018  |  Gary A. Enos, Contributing Editor
article

The 2017 National Survey on Drug Use and Health offers some encouragement regarding the opioid crisis but growing concern for groups such as pregnant women and young adults.

360 Behavioral Health acquires Southern California provider

September 17, 2018  |  Tom Valentino, Senior Editor
news

Passport to Adaptive Living will become part of 360 Behavioral Health’s California Psychcare unit.

5 essential healthcare policy questions for candidates

September 17, 2018  |  Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH
blog

As Election Day approaches, knowing where candidates stand on critical issues impacting our capacity to deliver care in the future is critical.

 

Advanced Recovery Systems acquires South Florida property out of bankruptcy

September 14, 2018  |  Tom Valentino, Senior Editor
news

Advanced Recovery Systems has purchased the real estate of The Treatment Center (of the Palm Beaches) and plans to open the facility near its home base in 2019.

Bridging the clinical-executive gap: How your ego is undoing your bottom line

September 13, 2018  |  Krista Gilbert, PhD, LMFT
Perspectives

Executives who lead from an ego-centered state run the risk of alienating staff and negatively impacting patient outcomes.

Fulcrum expands young-adult focus with acquisition of Life of Purpose

September 13, 2018  |  Gary A. Enos, Contributing Editor
article

Liberation Way and Life of Purpose Treatment Centers will now be joined under the umbrella of a new holding company, City Line Behavioral Healthcare. 

RAND center seeks deeper dive into opioid policy effectiveness

September 12, 2018  |  Gary A. Enos, Contributing Editor
news

Among its efforts, the RAND Opioid Policy Tools and Information Center will explore why certain opioid-fighting strategies work well in some communities but not others.

US firm invests in leading UK addiction treatment center operator

September 12, 2018  |  Tom Valentino, Senior Editor
news

UK Addiction Treatment Group, the largest private treatment center operator in the United Kingdom, has received an investment from Eli Global.

Blogs

5 essential healthcare policy questions for candidates

September 17, 2018     Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

As Election Day approaches, knowing where candidates stand on critical issues impacting our capacity to deliver care in the future is critical.

 

Be a voice for the recovery of trauma on 9/11

September 10, 2018     H. Steven Moffic

As a new 9/11 monument is unveiled, those in mental healthcare can make a contribution to the memory and heroism of that day through an indirect and symbolic approach.

NARMH conference calls attention to behavioral healthcare availability in rural areas

August 27, 2018     Ron Manderscheid, PhD, Exec Dir, NACBHDD and NARMH

New Orleans never disappoints and neither does the National Association for Rural Mental Health annual summer conference. When the two came together this past weekend, the effect was electric.

Next steps on the depression-opioid problem

August 13, 2018     Ron Manderscheid, Executive Director, NACBHDD and NARMH

Likely, the connection between depression and opioid use is so obvious that no one acts upon it or even talks about it. Yet, the consequences frequently are quite deadly. The issue: The failure to link depression treatment with opioid treatment.